Allergy & Immunology News 
This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 26.
La Jolla Institute Identifies Critical Cell In Fighting E. coli Infection
Finding Provides Potential New Therapeutic Target For Bacterial Infections Despite ongoing public health efforts, E. coli outbreaks continue to infiltrate the food supply, annually causing significant sickness and death throughout the world. But the research community is gaining ground. In a major finding, published today in the scientific journal Nature, researchers from the La Jolla Institute for Allergy & Immunology have discovered a molecule's previously unknown role in fighting off E...
Source: Health News from Medical News Today - July 19, 2012 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news
New Tool 'PDXomics' For Tumor Xenograft Research And Applications
BGI, the world's largest genomics organization, has announced that it has successfully developed a new filtering tool, PDXomics, which performs accurate and specific classification of the mixed reads derived from the host and tumor xenografts. Through the full utilization of this robust tool, researchers could develop the specific patient-derived xenografts (PDX) and advance the oncology drug discovery, biomarker development and their future applications. Xenograft models serve as an important tool for many areas of biomedical research, including oncology, immunology and HIV pathology...
Source: Health News from Medical News Today - July 19, 2012 Category: Consumer Health News Tags: Medical Devices / Diagnostics Source Type: news
NIH to Test Maraviroc-Based Drug Regimens for HIV Prevention
Source: National Institute of Allergy and Infectious Diseases -
Related MedlinePlus Page: HIV/AIDS Medicines
Source: MedlinePlus Health News - July 19, 2012 Category: Consumer Health News Source Type: news
Oral Immunotherapy Shows Promise for Children with Egg Allergy
Source: Physician's First Watch current issue - July 19, 2012 Category: Primary Care Tags: Medical News Source Type: news
Egg Allergy Cracked by Oral Immunotherapy (CME/CE)
(MedPage Today) -- Ingesting gradually larger amounts of egg protein may wipe out the allergy in children, researchers found.
Source: MedPage Today Pediatrics - July 18, 2012 Category: Pediatrics Source Type: news
Egg allergies 'treated with egg'
Omelettes, meringues and pasta could one-day be back on the menu for people with egg allergies after they are treated with the very food they are allergic to, say US researchers.
Source: BBC News | Health | UK Edition - July 18, 2012 Category: Consumer Health News Source Type: news
‘Egg Therapy’ May Help Allergic Kids
Exposing children with egg allergies to egg in a carefully-controlled setting can dramatically reduce and even eliminate potentially life-threatening allergic reactions for some children, new federally funded research shows.
Source: WebMD Health - July 18, 2012 Category: Consumer Health News Source Type: news
‘Exposure Therapy’ May Be Option for Kids’ Egg, Milk Allergies
Small studies found some children could tolerate food 'triggers' with gradual, medically supervised treatment
Source: The Doctors Lounge - Health News - July 18, 2012 Category: Consumer Health News Authors: webmaster at doctorslounge.com Tags: Pediatrics, Allergy, News, Source Type: news
Gradual exposure to egg cuts allergy risk
NEW YORK (Reuters Health) - Gradual exposure to egg white over about two years can reduce and sometimes eliminate a child's allergy to the food, according to a new study.
Source: Reuters: Health - July 18, 2012 Category: Consumer Health News Tags: healthNews Source Type: news
Oral Immunotherapy Effective in Egg Allergy TreatmentOral Immunotherapy Effective in Egg Allergy Treatment
Gradually exposing patients to increasing levels of egg white powder reduced egg sensitivity reactions in significant numbers of children and adolescents. Medscape Medical News
Source: Medscape Today Headlines - July 18, 2012 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news
Egg allergies reduced by desensitization, study finds
Children allergic to eggs who were fed small amounts of the food over a period of time saw their reactions reduced.
Source: USATODAY.com Health - July 18, 2012 Category: Consumer Health News Source Type: news
Markers May ID Kids Who Can Overcome Milk Allergy
(MedPage Today) -- Two chemotactic cytokines may hold potential as markers of the effectiveness of a desensitization protocol for children with a cow's milk allergy, researchers suggested.
Source: MedPage Today Pediatrics - July 18, 2012 Category: Pediatrics Source Type: news
Gradual Exposure to Egg Cuts Allergy Risk
Gradual exposure to egg white over about two years can reduce and sometimes eliminate a child's allergy to the food, according to a new study.
Source: Reuters Health
Related MedlinePlus Page: Food Allergy
Source: MedlinePlus Health News - July 18, 2012 Category: Consumer Health News Source Type: news
Physicians’ Experiences with EHR Adoption is Largely Positive
“Last November, we released data from the 2011 National Ambulatory Medical Care Survey (NAMCS) of office-based providers, finding that 57 percent had adopted an electronic health record (EHR), and 34 percent met all criteria for “basic EHR use” (patient history and demographics, patient problem list, physician clinical notes, comprehensive list of patient’s medications and allergies, [...]
Source: ICMCC: The International Council on Medical and Care Compunetics - July 18, 2012 Category: Information Technology Authors: Lodewijk Tags: News Adoption Physicians Satisfaction Source Type: news
Fighting E. Coli Infection With Newly Discovered Cell
Each year, E.coli outbreaks cause significant sickness and death around the world. Now, researchers have identified a molecule that is vital for fighting off E. coli and other bacterial infections. The study, conducted by researchers from the La Jolla Institute for Allergy & Immunology, is published in the journal Nature. Lead researcher of the study, Mitchell Kronenberg, Ph.D...
Source: Health News from Medical News Today - July 18, 2012 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news
Characterization of Single-Domain Antibodies with an Engineered Disulfide Bond
Camelidae single-domain antibodies (VHHs) represent a unique class of emerging therapeutics. Similar to other recombinant antibody fragments (e.g., Fabs, scFvs), VHHs are amenable to library screening and selection, but benefit from superior intrinsic biophysical properties such as high refolding efficiency, high solubility, no tendency for aggregation, resistance to proteases and chemical denaturants, and high expression, making them ideal agents for antibody-based drug design. Despite these favorable biophysical characteristics, further improvements to VHH stability are desirable when considering applications in adverse ...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Improvement of Single Domain Antibody Stability by Disulfide Bond Introduction
The successful medical application of single domain antibodies largely depends on their functionality. This feature is partly determined by the intrinsic stability of the single domain. Therefore a lot of research has gone into the elucidation of rules to uniformly increase stability of antibodies. Recently, a novel intra-domain disulfide bond was independently discovered by two research groups, after either rational design or careful investigation of the naturally occurring camelid antibody repertoire. By introducing this particular disulfide bond within a single domain antibody, the conformational stability can be increa...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Selection of Human VH Single Domains with Improved Biophysical Properties by Phage Display
Human antibody variable heavy (VH) domains tend to display poor biophysical properties when expressed in isolation. Consequently, the domains are often characterized by low expression levels, high levels of aggregation, and increased “stickiness.” Here, we describe methods that allow the engineering of human VH domains with improved biophysical properties by phage display. The engineered domains withstand challenging conditions, such as high temperature and acidic pH. Engineered human single domains are a promising new class of antibody fragments and represent robust research tools and building blocks for the g...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Improvement of Proteolytic Stability Through In Silico Engineering
VHHs usually display high physical and proteolytic stability, but in some cases stability needs to be increased further for their intended applications. The high thermal stability is due to the stable 3D structure of VHHs, which consists of a sandwich of nine beta-strands with a high number of intramolecular interactions, resulting in a very compact structure. Because of this compact structure, relatively low numbers of (basic) amino acids are accessible for proteases, explaining their usually high proteolytic stability. The high stability of VHHs is required when used as therapeutics given orally and nasally or when used ...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Solubility and Stability Engineering of Human VH Domains
Solubility and stability are amongst the factors contributing to the therapeutic efficacy of biologics. Human antibody heavy chain variable domains, VHs, are one class of biologics; improving VH biophysical properties is the focus of significant protein engineering efforts. Here, we describe an efficacy engineering approach which involves the introduction of a disulfide linkage in the VH core and which improves both VH solubility and stability. More specifically, we describe protocols for generation of disulfide engineered human VHs and their characterization in terms of disulfide linkage formation, non-aggregation, and st...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Selecting and Purifying Autonomous Human Variable Heavy (VH) Domains
Antibodies are invaluable macromolecules effectively utilized as detection reagents and therapeutics. Traditionally, researchers have relied upon the entire immunoglobulin molecule, however advances in protein engineering have ushered the use of antibody fragments as equally important biological tools such that at present, the downstream application generally dictates the antibody format employed. We provide herein robust and proven protocols for the isolation of autonomous human antibody variable heavy domains (VH). The strategy utilizes combinatorial phage-displayed libraries targeting human VH domain positions previousl...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Production of Camel-Like Antibodies in Plants
Transgenic plants for the production of high-value recombinant complex and/or glycosylated proteins are a promising alternative for conventional systems, such as mammalian cells and bacteria. Many groups use plants as production platform for antibodies and antibody fragments. Here, we describe how bivalent camel-like antibodies can be produced in leaves and seeds. Camel-like antibodies are fusions of the antigen-binding domain of heavy chain camel antibodies (VHH) with an Fc fragment of choice. Transient expression in Nicotiana benthamiana leaves allows the production of VHH-Fc antibodies within a few days after the expres...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Stable Expression of Chimeric Heavy Chain Antibodies in CHO Cells
Camelid single domain antibodies fused to noncamelid Fc regions, also called chimeric heavy chain antibodies (cHCAb), offer great potential as therapeutic and diagnostic candidates due to their relatively small size (80 kDa) and intact Fc. In this chapter, we describe two approaches, limiting dilution and minipools, for generating nonamplified Chinese hamster ovary cell lines stably expressing cHCAb in suspension and serum-free cultures using a stringent antibiotic selection. Neither of the protocols necessitates the acquisition or implementation of expensive automated infrastructures and thus could be applied in any lab w...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Expression of VHHs in Saccharomyces cerevisiae
The production of VHHs in microorganisms is relatively straightforward, however the amount of VHH produced per volume unit can vary substantially from hardly detectable to hundreds of milligrams per liter. Expression in Escherichia coli is more commonly used at initial research phase, since production of VHHs for large-scale application in E. coli is for a number of reasons not preferred. Otherwise VHH production in GRAS organisms such as Saccharomyces cerevisiae fits very well with industrial fermentation processes, and in fact the only commercially available VHHs are produced in S. cerevisiae. Immediately after the disco...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Expression of Single-Domain Antibodies in Bacterial Systems
We present different approaches for carrying out periplasmic and cytoplasmic expression, as well as small-scale and large-scale expression. In addition, we discuss the advantages and possible drawbacks of each protocol. We present data related to expression vectors, expression conditions, methods of protein extraction and purification, and yield and purity analysis of sdAbs. We also highlight important points that need to be considered before sdAbs that have been expressed in bacteria are used either in vitro or in vivo.
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Bacterial Two Hybrid: A Versatile One-Step Intracellular Selection Method
Many antibody fragments, selected ex vivo by phage display, fail to form functional antigen-binding entities when expressed and used intracellularly (i.e., as intrabodies) because the interior of the cell poses significant challenges on the folding of antibodies. Such dropout can be avoided by employing intracellular selection methods like yeast or bacterial two hybrid systems. These involve four facile steps: construction of plasmids, transformation of microbial cells, intracellular expression of fusion proteins, and selection for reporter activity. Using E. coli as host instead of yeast offers the advantages of a faster ...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Pichia Surface Display: A Tool for Screening Single Domain Antibodies
Yeast surface display is being employed as an efficient tool for the isolation and engineering of traditional antibody fragments, both scFv and Fab, as well as single domain antibodies. Here we describe the protocols for a yeast surface display system developed in the methylothrophic yeast Pichia pastoris, the most commonly used yeast species for protein production. In this system the immune or maturated library of single domain antibodies is fused to the C-terminal domain of Saccharomyces cerevisiae alpha-agglutinin gene (SAG1) and expressed on the surface of P. pastoris cells. Labeling with ligands enables rapid and quan...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Semiautomated Panning of Naive Camelidae Libraries and Selection of Single-Domain Antibodies Against Peptide Antigens
With the identification of vast numbers of novel proteins through genomic and proteomic initiatives, the need for efficient processes to characterize and target them has increased. Antibodies are naturally designed molecules that can fulfill this need, and in vitro methodologies for isolating them from either immune or naïve sources have been extensively developed. However, access to pure protein antigens for screening purposes is a major hurdle due to the limitations associated with recombinant production of eukaryotic proteins. Consequently, rational peptide design based on proteomic methodologies such as protein mo...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Selection by Phage Display of Single Domain Antibodies Specific to Antigens in Their Native Conformation
Phage display of antibody fragments and other binding molecules is a well-established technique to identify ligands interacting with any molecule of interest. Selection of in vivo matured single domain antibody fragments from phage display libraries is very powerful as in these libraries each clone represents a noncombinatorial functional domain of a naturally circulating antibody, and thus such libraries contain a high number of antigen-specific clones. Consequently, individual binders to antigens of interest are efficiently obtained typically after one or two selection rounds. Furthermore, the large functional diversity ...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Selection of VHH Antibody Fragments That Recognize Different Aβ Depositions Using Complex Immune Libraries
Phage display technology is frequently used to obtain antigen specific binders with predetermined characteristics. Phage display libraries are often constructed from animals immunized with the antigen of interest. An important point of consideration when making immune libraries is the availability of an appropriate antigen sources. When available, often either the amount is not sufficient for immunization or it is expensive to obtain. To overcome this problem, these antigens are typically obtained by over expression in prokaryotic or eukaryotic expression systems. While this could solve the problem of obtaining sufficient ...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Isolation and Characterization of Clostridium difficile Toxin-Specific Single-Domain Antibodies
Camelidae single-domain antibodies (VHHs) are a unique class of small binding proteins that are promising inhibitors of targets relevant to infection and immunity. With VHH selection from hyperimmunized phage display libraries now routine and the fact that VHHs possess long, extended complementarity-determining region (CDR3) loop structures that can access traditionally immunosilent epitopes, VHH-based inhibition of targets such as bacterial toxins are being explored. Toxin A and toxin B are high molecular weight exotoxins (308 kDa and 269 kDa, respectively) secreted by Clostridium difficile that are the causative agents o...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Selection of VHHs Under Application Conditions
The successful application of antibody fragments such as VHHs in diagnostic assays, affinity purification, imaging, or therapy is not determined by the specificity and affinity of the antibody fragment alone. The ability to bind the target protein in the environment in which the antibody fragment is intended to functionally perform determines to a great extent its success. To identify antibodies with the required stability profile selection of naturally occurring variants from an immune library or mutants from an engineered library should be performed via phage display. The conditions under which the designed antibodies di...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Cell-Free Selection of Domain Antibodies by In Vitro Compartmentalization
Efficient identification of antibodies, or any fragments thereof, displaying desired specificity and affinity is critical for the development of novel immunotherapeutics. Here we describe the adaptation of in vitro compartmentalization for the cell-free selection of Vκ and VH domain antibodies (dAbs™) from large combinatorial libraries. The dAbs™ are in vitro expressed in fusion to the N-terminus of single-chain variant of phage P22 Arc repressor DNA-binding domain that links the compartmentally expressed protein molecules to their encoding PCR fragment-based genes via cognate operator sites present on th...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Selection of Functional Single Domain Antibody Fragments for Interfering with Protein–Protein Interactions Inside Cells: A “One Plasmid” Mammalian Two-Hybrid System
As a complement to the intracellular antibody capture method to isolate intracellular single domain antibody fragments (iDabs) from high diverse libraries, we describe here a simple mammalian two-hybrid (M2H) protocol using a “bait-prey hybrid single plasmid” to assess those interfering iDabs that will block protein–protein interactions of a target with its natural partner proteins. This rapid method identifies interfering iDabs in one step and improves the reproducibility of the results between experiments and samples (e.g., different single domain antibody clones) compared to traditional M2H. This metho...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Intracellular Antibody Capture (IAC) Methods for Single Domain Antibodies
We describe here the new generation protocol for intracellular antibody capture to facilitate selection of functional single domains. This protocol uses a series of optimized single domain libraries, based on designed intracellular variable (VH or VL) region scaffolds, for direct in vivo isolation of single domains that bind to target proteins and interaction and for affinity maturation to develop sub-nM affinity antibody fragments. The method has advantages over other methods in that specific single domains are isolated directly within the reducing cellular environment and can be selected without in vitro antigen protein preparation.
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Preparation of a Naïve Library of Camelid Single Domain Antibodies
The preparation of antibody libraries starting from lymphocytes recovered from immunized members of the Camelidae enables to collect binders that underwent somatic maturation. However, the time and costs necessary to prepare a library for each new antigen may urge to look for alternatives such as those offered by large one-pot libraries. Here we describe how to obtain a suitable naïve library using material from nonimmunized llamas. Despite the lack of somatic maturation, the selection based on phage display allowed to isolate from such naïve libraries VHHs with affinity in the subnanomolar range and suitable for...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Creation of the Large and Highly Functional Synthetic Repertoire of Human VH and Vκ Domain Antibodies
This protocol describes a method for creation of a highly diverse and functional synthetic phage-displayed repertoire of fully human domain antibodies (dAbs). The repertoire is based on two human frameworks (one VH and one Vκ) that express well in bacteria and are frequently used in human antibodies. To achieve this, we first build dAb libraries, containing full synthetic diversity at key positions in the complementarity-determining regions (CDRs). We then use an antigen-independent preselection of this primary dAb repertoire on generic ligands of the VH and the Vκ scaffolds (namely, the bacterial superantigens...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Overview and Discovery of IgNARs and Generation of VNARs
Immunoglobulin new antigen receptors (IgNARs) from sharks are a distinct class of immune receptors, consisting of homodimers with no associated light chains. Antigen binding is encapsulated within single VNAR immunoglobulin domains of 13–14 kDa in size. This small size and single domain format means that they exhibit considerable stability and are readily produced in heterologous protein expression systems. In this chapter, I describe the history and discovery of IgNARs, the development of VNAR biotechnology, and highlight important factors in VNAR protein production.
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
Introduction to Heavy Chain Antibodies and Derived Nanobodies
The immune response of infected or immunized dromedaries contains a diverse repertoire of conventional and heavy chain-only antibodies, both functional in antigen binding. By definition, a heavy chain antibody is devoid of a light chain and in the case of the heavy chain antibodies in camelids the CH1 domain is also missing. Consequently a camelid heavy chain antibody associates with its cognate antigen via a single domain, the variable heavy chain domain of a heavy chain antibody or VHH. An antigen-specific VHH, also known as Nanobody, with excellent biochemical properties can be obtained in various ways. Their recombinan...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
From Whole Monoclonal Antibodies to Single Domain Antibodies: Think Small
The development of therapeutic monoclonal antibodies over the last 35 years has led to the emergence of a new class of useful therapeutic molecules. These “first generation” antibodies have been obtained thanks to the conjugated and huge efforts of both academic and biotech researchers. About 30 monoclonal antibodies are currently approved for therapeutic use in Europe, USA, and China. Strikingly, only a restricted number of these antibodies are immunoglobulin fragments, single variable domains, or multiunit formats based on the engineering of immunoglobulin variable domains. In the present chapter, we will rev...
Source: Springer protocols feed by Immunology - July 18, 2012 Category: Allergy & Immunology Source Type: news
NIH to test maraviroc-based drug regimens for HIV prevention
(NIH/National Institute of Allergy and Infectious Diseases) Scientists are launching the first clinical trial to test whether drug regimens containing maraviroc, a medication currently approved to treat HIV infection, are also safe and tolerable when taken once daily by HIV-uninfected individuals at increased risk for acquiring HIV infection. The eventual goal is to see if the drug regimens can reduce the risk of infection.
Source: EurekAlert! - Social and Behavioral Science - July 18, 2012 Category: Global & Universal Source Type: news
Botanical compound could prove crucial to healing influenza
(Virginia Tech) Building on previous work with the botanical abscisic acida, researchers in the Nutritional Immunology and Molecular Medicine Laboratory (NIMML) have discovered that abscisic acid has anti-inflammatory effects in the lungs as well as in the gut. The results will be published in the Journal of Nutritional Biochemistry.
Source: EurekAlert! - Medicine and Health - July 18, 2012 Category: Global & Universal Source Type: news
£20m donation for Cancer research
A donor, who wishes to remain anonymous, has given £20m to fund cancer immunology in the UK, BBC's Newsnight has learnt.
Source: BBC News | Health | UK Edition - July 17, 2012 Category: Consumer Health News Source Type: news
Tick bites may cause allergies
Susan Hendricks reports on new findings that tick bites may cause allergies in some people.
Source: CNN.com - Health - July 17, 2012 Category: Consumer Health News Source Type: news
Dendritic Cells Key To Activating Human Immune Responses
Scientists at A*STAR's Singapore Immunology Network (SIgN), in collaboration with Newcastle University, UK, the Singapore Institute of Clinical Sciences and clinicians from multiple hospitals in Singapore, have identified a new subset of dendritic cells (DCs) in human peripheral tissue which have a critical role in activating our immune response against harmful pathogens. This research will have significant impact on the design of vaccines and other targeted immunotherapies...
Source: Health News from Medical News Today - July 17, 2012 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news
Critical Cell In Fighting E. coli Infection Identified
Despite ongoing public health efforts, E. coli outbreaks continue to infiltrate the food supply, annually causing significant sickness and death throughout the world. But the research community is gaining ground. In a major finding, published in the scientific journal Nature, researchers from the La Jolla Institute for Allergy & Immunology have discovered a molecule's previously unknown role in fighting off E. coli and other bacterial infections, a discovery that could lead to new ways to protect people from these dangerous microorganisms...
Source: Health News from Medical News Today - July 17, 2012 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news
Seasonal allergies: Nip them in the bud
Seasonal allergies — Tips and treatments.
Source: MayoClinic.com Full Feed - July 17, 2012 Category: Consumer Health News Source Type: news
Tips from the journals of the American Society for Microbiology
(American Society for Microbiology) In this month's issue: Package Inserts Overstate Diagnostic TB Tests' Accuracy; UVC Light Kills Wound Bacteria; Copper Surfaces Could Reduce Hospital Acquired Infections; Penile Foreskin Is Immunologically Complete: Raises New Vaccine Possibilities For HIV Vaccine.
Source: EurekAlert! - Medicine and Health - July 17, 2012 Category: Global & Universal Source Type: news
World Allergy Organization Guidelines for Anaphylaxis ManagementWorld Allergy Organization Guidelines for Anaphylaxis Management
Gain an updated global perspective on patient risk factors, triggers, diagnosis and more regarding anaphylaxis prevention. Current Opinion in Allergy and Clinical Immunology
Source: Medscape Today Headlines - July 16, 2012 Category: Consumer Health News Tags: Allergy & Clinical Immunology Journal Article Source Type: news
